White label ELPA - ClinicalTrials.eu

Study on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism

Recruiting

3 1 1 1
Investigated diseases:
- Pulmonary embolism
Investigated drugs:
- Oxygen
Study on Metronomic Chemotherapy for Children and Teenagers with Relapsed or Refractory Wilms Tumor Using Vincristine, Irinotecan, Etoposide, Temozolomide, and Isotretinoin

Recruiting

2 1 1 1
Investigated drugs:
Study on Sodium Glycocholate and Sodium Butyrate for Calcium Absorption in Women with Obesity After Gastric Bypass

Recruiting

2 1 1
Investigated drugs:
- Sodium Butyrate
- Sodium Glycocholate
Study on Apomorphine and Psilocybin for Recovery in Coma Patients with Acute Brain Injury

Recruiting

1 1 1
Investigated diseases:
- Coma
Investigated drugs:
Study on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- Triptorelin
- Darolutamide
Study Comparing Methylprednisolone Aceponate Creams and a Non-Active Cream for Patients with Mild to Moderate Atopic Dermatitis

Recruiting

3 1 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
- Methylprednisolone Aceponate
Study on Pain Relief for Limb Injuries in Children: Comparing Intranasal Fentanyl, Intranasal Ketamine, and Oral Morphine in Patients Aged 2-17 Years

Recruiting

4 1 1
Investigated drugs:
Study on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia

Recruiting

1 1 1 1
Investigated diseases:
Investigated drugs:
- Asciminib
- Asciminib Hydrochloride
+1
Study on Dornase Alfa and Placebo to Reduce ARDS in Ventilated Trauma Patients in ICU

Recruiting

3 1 1
Investigated diseases:
- Acute respiratory distress syndrome
Investigated drugs:
- Dornase Alfa
- Sodium Chloride
Study Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab

Recruiting

3 1 1 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- Adalimumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies